Analyst Profile

Followed by 396 followers
.
David Toung

David Toung

Argus Research
Wall Street Analyst
#544 out of 8,141 Wall Street Analysts
#1,059 out of 24,284 experts

Success Rate

67%
130 out of 194 transactions made a profit

Average Return

+10.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying David Toung's trades since 2015 and holding each position for 1 Year would result in 67.01% of your transactions generating a profit, with an average return of 10.8% per rating.

Stock Rating Distribution

253Ratings
79.05% Buy
20.95% Hold
0.00% Sell
Distribution of David Toung's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Charles River Laboratories Intl
(CRL)
Rating:Buy
Date:Sep 14, 2020 - Sep 14, 2021
Return:+98.20%
The most profitable rating made by David Toung

David Toung's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CERN
Cerner
Mar 23, 2015
Buy
Reiterated
4Ratings
50%
+3.63%
National Storage Affiliates
Apr 05, 2016
Hold
Downgraded
$21.00
(-47.25% Downside)
1Ratings
0.00%
Baxter International
Aug 15, 2016
Hold
Reiterated
3Ratings
0.00%
ESRX
Express Scripts
Aug 24, 2016
Hold
Reiterated
2Ratings
0.00%
STJ
St Jude Medical
Aug 26, 2016
Hold
Reiterated
2Ratings
0.00%
Boston Scientific
Sep 01, 2016
Buy
Upgraded
$33.00
(-27.10% Downside)
5Ratings
100%
+13.00%
Allscripts
Oct 21, 2016
Buy
Reiterated
$19.00
(0.32% Upside)
3Ratings
50%
+5.65%
AET
Aetna Inc
Dec 06, 2017
Hold
Downgraded
9Ratings
100%
+21.41%
AGN
Allergan
Dec 07, 2017
Hold
Downgraded
6Ratings
20%
-10.50%
Biogen
Feb 16, 2018
Hold
Downgraded
1Ratings
0.00%
List of latest recommendations made by David Toung. Click to expand and see David Toung's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >